Cargando…
SUMO3 modification by PIAS1 modulates androgen receptor cellular distribution and stability
BACKGROUND: Abnormal reactivation of androgen receptor (AR) signaling in castration-resistant prostate cancer (CRPC) mainly results from overexpression and down-regulation of AR. Sumoylation of AR can influence its function. However, regulation of AR sumoylation by SUMO E3 ligases PIASs to modify AR...
Autores principales: | Yang, Nanyang, Liu, Sitong, Qin, Tian, Liu, Xintong, Watanabe, Nobumoto, Mayo, Kevin H., Li, Jiang, Li, Xiaomeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868827/ https://www.ncbi.nlm.nih.gov/pubmed/31752909 http://dx.doi.org/10.1186/s12964-019-0457-9 |
Ejemplares similares
-
Tomosyn Interacts with the SUMO E3 Ligase PIASγ
por: Geerts, Cornelia J., et al.
Publicado: (2014) -
SUMO ligase PIAS1 functions as a target gene selective androgen receptor coregulator on prostate cancer cell chromatin
por: Toropainen, Sari, et al.
Publicado: (2015) -
PIAS-family proteins negatively regulate Glis3 transactivation function through SUMO modification in pancreatic β cells
por: Hoard, Tyler M., et al.
Publicado: (2018) -
SUMO-2 and PIAS1 Modulate Insoluble Mutant Huntingtin Protein Accumulation
por: O’Rourke, Jacqueline Gire, et al.
Publicado: (2013) -
Quantitative SUMO proteomics identifies PIAS1 substrates involved in cell migration and motility
por: Li, Chongyang, et al.
Publicado: (2020)